BGLC icon

BioNexus Gene Lab
BGLC

3 hedge funds and large institutions have $37.3K invested in BioNexus Gene Lab in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
3
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$23.3K
2
+$8.4K

Top Sellers

1
-$30.7K
2
-$9.17K
3
-$3.02K
4
Morgan Stanley
Morgan Stanley
New York
-$162
5
JP Morgan Chase & Co
JP Morgan Chase & Co
New York
-$162
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
1
Citadel Advisors
Florida
$23.3K
Two Sigma Investments
2
Two Sigma Investments
New York
$8.4K
Geode Capital Management
3
Geode Capital Management
Massachusetts
$5.6K
UBS Group
4
UBS Group
Switzerland
$1
XT
5
XTX Topco
Cayman Islands
–
SRL
6
Scientech Research LLC
New Jersey
–
Morgan Stanley
7
Morgan Stanley
New York
–
JP Morgan Chase & Co
8
JP Morgan Chase & Co
New York
–